Details for New Drug Application (NDA): 020472
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
The generic ingredient in ESTRING is estradiol. There are seventy-five drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the estradiol profile page.
Summary for 020472
Tradename: | ESTRING |
Applicant: | Pfizer |
Ingredient: | estradiol |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 020472
Mechanism of Action | Estrogen Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 020472
Suppliers and Packaging for NDA: 020472
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ESTRING | estradiol | INSERT, EXTENDED RELEASE;VAGINAL | 020472 | NDA | Pfizer Laboratories Div Pfizer Inc | 0013-1042 | 0013-1042-01 | 1 POUCH in 1 CARTON (0013-1042-01) / 1 SYSTEM in 1 POUCH |
ESTRING | estradiol | INSERT, EXTENDED RELEASE;VAGINAL | 020472 | NDA | Pfizer Laboratories Div Pfizer Inc | 0013-2150 | 0013-2150-36 | 1 POUCH in 1 CARTON (0013-2150-36) / 1 RING in 1 POUCH |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INSERT, EXTENDED RELEASE;VAGINAL | Strength | 0.0075MG/24HR | ||||
Approval Date: | Apr 26, 1996 | TE: | RLD: | Yes |
Expired US Patents for NDA 020472
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | ESTRING | estradiol | INSERT, EXTENDED RELEASE;VAGINAL | 020472-001 | Apr 26, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | ESTRING | estradiol | INSERT, EXTENDED RELEASE;VAGINAL | 020472-001 | Apr 26, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription